SCHEMBL7418015

SCHEMBL7418015

CC(C)(C)c1ccc(S(=O)(=O)N[C@@H](Cc2ccc(OCCCONC(=N)N)cc2)C(=O)OC(=O)C(F)(F)F)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
MAPT P10636 1/20 0.46
F2 P00734 2/20 0.41
TMPRSS6 Q8IU80 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
ITGB3 P05106 3/20 0.40
ITGA2B P08514 3/20 0.40
F10 P00742 2/20 0.40
PLG P00747 1/20 0.40
GPR35 Q9HC97 1/20 0.39
KDM4E B2RXH2 1/20 0.39
KDM4A O75164 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
ADAMTS4 O75173 1/20 0.38
MMP13 P45452 1/20 0.38
KCNA5 P22460 1/20 0.37
LMNA P02545 2/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7699241 0.93 F2 (0.39) ALDH1A1MAPTF2TMPRSS6L3MBTL1
SCHEMBL7415235 0.93 KCNA5 (0.44) F2TMPRSS6L3MBTL1ITGB3ITGA2B
SCHEMBL7416574 0.92 ITGB3 (0.45) F2TMPRSS6L3MBTL1ITGB3ITGA2B
SCHEMBL7694791 0.92 MMP2 (0.45) F2TMPRSS6ITGB3ITGA2BADAMTS4
SCHEMBL7699209 0.91 F2 (0.42) F2TMPRSS6L3MBTL1ITGB3ITGA2B
SCHEMBL7418524 0.90 F2 (0.43) ALDH1A1F2TMPRSS6ITGB3ITGA2B
SCHEMBL7413464 0.90 F2 (0.42) F2TMPRSS6L3MBTL1ITGB3ITGA2B
SCHEMBL7412629 0.90 CTSL (0.43) F2TMPRSS6L3MBTL1ITGB3ITGA2B
SCHEMBL7414434 0.90 F2 (0.42) ALDH1A1F2TMPRSS6L3MBTL1ITGB3
SCHEMBL7417592 0.90 ITGB3 (0.49) F2TMPRSS6ITGB3ITGA2BMMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6344484-B1 TREATMENT OF TUMOR GROWTH, METASTASIS, OSTEOPOROSIS, RESTENOSIS, INFLAMMATION, MACULAR DEGENERATION, DIABETIC RETINOPATHY, AND RHEUMATOID ARTHRITIS 3-DIMENSIONAL PHARMACEUTICALS, INC. 2002-02-05 US disclosed
EP-1159262-A1 TYROSINE ALKOXYGUANIDINES AS INTEGRIN INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2001-12-05 EP disclosed
WO-2000047552-A1 TYROSINE ALKOXYGUANIDINES AS INTEGRIN INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2000-08-17 WO disclosed